πŸ‡ΊπŸ‡Έ FDA
Patent

US 8076353

Inhibition of VEGF translation

granted A61KA61K31/437A61K31/497

Quick answer

US patent 8076353 (Inhibition of VEGF translation) held by PTC THERAPEUTICS, INC. expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
39
CPC classes
A61K, A61K31/437, A61K31/497, A61K31/5377, A61K31/541